These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7603648)

  • 1. MK-801 subsensitivity following postweaning lead exposure.
    Cory-Slechta DA
    Neurotoxicology; 1995; 16(1):83-95. PubMed ID: 7603648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postweaning lead exposure enhances the stimulus properties of N-methyl-D-aspartate: possible dopaminergic involvement?
    Cory-Slechta DA; Pokora MJ; Johnson JL
    Neurotoxicology; 1996; 17(2):509-21. PubMed ID: 8856745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal lead exposure and MK-801 sensitivity.
    Cory-Slechta DA
    Neurotoxicology; 1997; 18(1):209-20. PubMed ID: 9216003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo.
    Gilbert ME; Lasley SM
    Neurotoxicol Teratol; 2007; 29(3):385-93. PubMed ID: 17350801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead-induced changes in muscarinic cholinergic sensitivity.
    Cory-Slechta DA; Pokora MJ
    Neurotoxicology; 1995; 16(2):337-47. PubMed ID: 7566693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
    Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
    Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subsensitivity of lead-exposed rats to the accuracy-impairing and rate-altering effects of MK-801 on a multiple schedule of repeated learning and performance.
    Cohn J; Cory-Slechta DA
    Brain Res; 1993 Jan; 600(2):208-18. PubMed ID: 8435747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental lead exposure alters N-methyl-D-aspartate and muscarinic cholinergic receptors in the rat hippocampus: an autoradiographic study.
    Jett DA; Guilarte TR
    Neurotoxicology; 1995; 16(1):7-18. PubMed ID: 7603647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate and dopamine in nucleus accumbens core and shell: sequence learning versus performance.
    Bauter MR; Brockel BJ; Pankevich DE; Virgolini MB; Cory-Slechta DA
    Neurotoxicology; 2003 Mar; 24(2):227-43. PubMed ID: 12606295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination.
    France CP; Moerschbaecher JM; Woods JH
    J Pharmacol Exp Ther; 1991 May; 257(2):727-34. PubMed ID: 2033515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
    Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
    Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methyl-D-aspartate receptors in associative eyeblink conditioning: both MK-801 and phencyclidine produce task- and dose-dependent impairments.
    Thompson LT; Disterhoft JF
    J Pharmacol Exp Ther; 1997 May; 281(2):928-40. PubMed ID: 9152403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
    Koek W; Woods JH; Colpaert FC
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1017-25. PubMed ID: 2193142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W; Woods JH; Winger GD
    J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D; Zhang J; Engel JA; Svensson L
    Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection.
    Koek W; Colpaert FC; Vignon J
    J Pharmacol Exp Ther; 1993 Feb; 264(2):746-56. PubMed ID: 8437123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead inhibits the rat N-methyl-d-aspartate receptor channel by binding to a site distinct from the zinc allosteric site.
    Lasley SM; Gilbert ME
    Toxicol Appl Pharmacol; 1999 Sep; 159(3):224-33. PubMed ID: 10486309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
    Seillier A; Giuffrida A
    Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.